This recent transaction increases Robin Ferracone’s holding in the company by 54.2% to a total of $1.35 million. Following Robin Ferracone’s last TRUP Buy transaction on February 23, 2017, the stock climbed by 8.1%.
Based on Trupanion’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $78.16 million and quarterly net profit of $1.21 million. In comparison, last year the company earned revenue of $63.12 million and had a net profit of $406K. Currently, Trupanion has an average volume of 668K.
Based on 3 analyst ratings, the analyst consensus is Strong Buy with an average price target of $41.67, reflecting a 71.6% upside. Starting in December 2017, TRUP received 21 Buy ratings in a row. Three different firms, including C.L. King and Canaccord Genuity, currently also have a Buy rating on the stock.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the Subscription Business and Other Business segments. The Subscription Business segment involves in the monthly subscriptions of pet medical insurance.